News | May 04, 2026
Moderna posts Q1 2026 loss despite revenue surge
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Growth was supported by stronger COVID vaccine sales and expanded government supply agreements in international markets
Early implementation of West Synchrony S1 platform aims to accelerate biologics and vaccine development while reducing manufacturing risk for biopharma partners
The 4,000-square-foot facility is designed as a hands-on hub where customers can work directly with scientists and engineers
While Drugs for Neglected Diseases initiative (DNDi) drives the R&D for neglected diseases, we collaborate with pharmaceutical companies at multiple stages, including sourcing promising molecules
Pharma and biotech infrastructure firm targets 25–30% growth as Middle East and Africa emerge as key expansion markets
Over the past decade, IIL has maintained a strong growth trajectory, registering a compound annual growth rate (CAGR) of 16%
At IIT Roorkee’s Vision 2047 conference, the union minister highlights BioE3 policy, rising biotech startups, and major scientific milestones
Our company is prioritising deeper collaborations with CDMOs and biosimilar companies as part of its strategy to expand its footprint across India, Middle East, and Africa region
Stakeholders call for coordinated action on diagnostics, vaccines, and health system readiness as the monsoon season approaches
The approval, following a positive recommendation from the European Medicines Agency’s CHMP, makes the vaccine valid across all 27 EU member states
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
